6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Psycho-Oncology and Substance Use Disorders
Psycho-oncology addresses the psychological and emotional challenges faced by cancer patients, including the intersection with substance use disorders (SUDs). Cancer diagnosis and treatment often lead to emotional distress, prompting some individuals to misuse substances as a coping mechanism. Conversely, prolonged substance use increases cancer risks due to carcinogenic exposure and weakened immune responses. Integrating SUD screening into oncology care allows for early identification and intervention. Multidisciplinary approaches, involving oncologists, psychiatrists, and addiction specialists, ensure holistic care. Tailored treatments that address both cancer-related distress and substance use can improve quality of life and treatment outcomes for affected individuals.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States